PLATELETS AND THE VESSEL WALL: HOW MUCH ASPIRIN?
- 16 February 1980
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 315 (8164), 371-373
- https://doi.org/10.1016/s0140-6736(80)90923-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- DIFFERENTIAL INHIBITION OF PROSTACYCLIN PRODUCTION AND PLATELET AGGREGATION BY ASPIRINThe Lancet, 1979
- Prevention of Thrombosis in Patients on Hemodialysis by Low-Dose AspirinNew England Journal of Medicine, 1979
- Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal's anginaProstaglandins and Medicine, 1979
- Use of a radioimmunoassay to study thrombin-induced release of PGI2 from cultured endotheliumThrombosis Research, 1979
- ASPIRIN: A PARADOXICAL EFFECT ON BLEEDING-TIMEThe Lancet, 1978
- ASPIRIN, THROMBOXANE, AND PROSTACYCLIN IN RATS: A DILEMMA RESOLVED?The Lancet, 1978
- PROSTACYCLIN-LIKE ACTIVITY AND BLEEDING IN RENAL FAILUREThe Lancet, 1977
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- TWO IN-VIVO STUDIES COMPARING HIGH AND LOW ASPIRIN DOSAGEThe Lancet, 1971
- A comparison of an effect of different anti-inflammatory drugs on human plateletsJournal of Clinical Pathology, 1970